P01021 (BNP_GLOBL) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 56.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Bradykinin-potentiating and C-type natriuretic peptides Alternative name(s): Angiotensin-converting enzyme inhibitor BPP-CNP homolog Cleaved into the following 9 chains:
|
| Organism | Gloydius blomhoffii (Mamushi) (Agkistrodon halys blomhoffi) |
| Taxonomic identifier | 242054 [NCBI] |
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Lepidosauria › Squamata › Scleroglossa › Serpentes › Colubroidea › Viperidae › Crotalinae › Gloydius![]() |
Protein attributes
| Sequence length | 263 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Blomhotin: inhibits the rabbit lung angiotensin-converting enzyme (ACE) with an IC50 of 15 µM. Ref.6 Ref.8 Bradykinin-potentiating peptide A: causes no contraction of the rat gastric fundus smooth muscle even at high concentrations. Ref.6 Ref.8 Bradykinin-potentiating peptide B: inhibits the activity of the angiotensin-converting enzyme (ACE) by a preferential interaction with its C-domain. Also potentiates the hypotensive effects of bradykinin. Inhibits the rabbit lung ACE with an IC50 of 1.1 µM. Ref.6 Ref.8 Bradykinin-potentiating peptide C: inhibits the activity of the angiotensin-converting enzyme (ACE) by interacting with the same potency to its C- and N-domains (Ref.7). Inhibits the rabbit lung angiotensin-converting enzyme (ACE) with an IC50 of 7.1 µM. Ref.6 Ref.8 Leu3-blomhotin: inhibits the rabbit lung angiotensin-converting enzyme (ACE) with an IC50 of 46 µM. Synthetic Leu3-blomhotin contracts the rat gastric fundus smooth muscle in a rapid and transient manner. Ref.6 Ref.8 Bradykinin-potentiating peptide Ahb1: potentiates the bradykinin in vivo. Ref.6 Ref.8 Bradykinin-potentiating peptide Ahb2: does not show any bradykinin-potentiating effects. Ref.6 Ref.8 C-type natriuretic peptide: exhibits hypotensive and vasodepressor activity. Acts by activating natriuretic receptors (NPR1 and/or NPR2 and/or NPR3) By similarity. Ref.6 Ref.8 |
| Subcellular location | |
| Tissue specificity | Expressed by the venom gland. |
| Sequence similarities | In the N-terminal section; belongs to the bradykinin-potentiating peptide family. In the C-terminal section; belongs to the natriuretic peptide family. |
| Mass spectrometry | Molecular mass is 1073.3 Da from positions 49 - 59. Determined by ESI. Ref.6 |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Secreted |
| Domain | Repeat Signal |
| Molecular function | Hypotensive agent Metalloenzyme inhibitor Metalloprotease inhibitor Protease inhibitor Toxin Vasoactive Vasodilator |
| PTM | Cleavage on pair of basic residues Disulfide bond Pyrrolidone carboxylic acid |
| Technical term | 3D-structure Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological_process | regulation of blood pressure Inferred from electronic annotation. Source: UniProtKB-KW vasodilationInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular_component | extracellular region Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular_function | metalloendopeptidase inhibitor activity Inferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||
Molecule processing | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 23 | 23 | Potential | |||||||
| Propeptide | 24 – 30 | 7 | Potential | PRO_0000334172 | ||||||
| Peptide | 31 – 41 | 11 | Blomhotin Ref.2 | PRO_5000049304 | ||||||
| Peptide | 31 – 40 | 10 | Bradykinin-potentiating peptide A Ref.3 | PRO_5000049303 | ||||||
| Propeptide | 42 – 48 | 7 | Potential | PRO_0000334173 | ||||||
| Peptide | 49 – 59 | 11 | Leu3-blomhotin | PRO_5000049305 | ||||||
| Propeptide | 60 – 66 | 7 | Potential | PRO_0000334174 | ||||||
| Peptide | 67 – 77 | 11 | Bradykinin-potentiating peptide C Ref.4 | PRO_5000049306 | ||||||
| Propeptide | 78 – 84 | 7 | Potential | PRO_0000334175 | ||||||
| Peptide | 85 – 95 | 11 | Bradykinin-potentiating peptide B Ref.5 | PRO_5000049307 | ||||||
| Propeptide | 96 – 102 | 7 | Potential | PRO_0000334176 | ||||||
| Peptide | 103 – 113 | 11 | Bradykinin-potentiating peptide B | PRO_5000049308 | ||||||
| Propeptide | 114 – 116 | 3 | Potential | PRO_0000334177 | ||||||
| Peptide | 117 – 127 | 11 | Bradykinin-potentiating peptide E By similarity | PRO_5000049309 | ||||||
| Peptide | 117 – 121 | 5 | Bradykinin-potentiating peptide Ahb1 By similarity | PRO_0000342453 | ||||||
| Propeptide | 128 – 239 | 112 | Potential | PRO_0000334178 | ||||||
| Peptide | 131 – 136 | 6 | Bradykinin-potentiating peptide Ahb2 By similarity | PRO_0000342454 | ||||||
| Peptide | 242 – 263 | 22 | C-type natriuretic peptide | PRO_5000049310 | ||||||
Regions | ||||||||||
| Compositional bias | 34 – 136 | 103 | Pro-rich | |||||||
| Compositional bias | 226 – 231 | 6 | Poly-Gly | |||||||
Amino acid modifications | ||||||||||
| Modified residue | 31 | 1 | Pyrrolidone carboxylic acid | |||||||
| Modified residue | 49 | 1 | Pyrrolidone carboxylic acid | |||||||
| Modified residue | 67 | 1 | Pyrrolidone carboxylic acid | |||||||
| Modified residue | 85 | 1 | Pyrrolidone carboxylic acid | |||||||
| Modified residue | 103 | 1 | Pyrrolidone carboxylic acid | |||||||
| Modified residue | 117 | 1 | Pyrrolidone carboxylic acid By similarity | |||||||
| Disulfide bond | 247 ↔ 263 | By similarity | ||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Bradykinin-potentiating peptides and C-type natriuretic peptides from snake venom." Higuchi S., Murayama N., Saguchi K., Ohi H., Fujita Y., de Camargo A.C.M., Ogawa T., Deshimaru M., Ohno M. Immunopharmacology 44:129-135(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Venom gland. |
| [2] | "Blomhotin: a novel peptide with smooth muscle contractile activity identified in the venom of Agkistrodon halys blomhoffii." Yanoshita R., Kasuga A., Inoue S., Ikeda K., Samejima Y. Toxicon 37:1761-1770(1999) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 31-41, PYROGLUTAMATE FORMATION AT GLN-31. Tissue: Venom. |
| [3] | "Structure of potentiator A, one of the five bradykinin potentiating peptides from the venom of Agkistrodon halys blomhoffii." Kato H., Suzuki T., Okada K., Kimura T., Sakakibara S. Experientia 29:574-575(1973) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 31-40, PYROGLUTAMATE FORMATION AT GLN-31. Tissue: Venom. |
| [4] | "Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffi. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and C." Kato H., Suzuki T. Biochemistry 10:972-980(1971) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 67-77, PYROGLUTAMATE FORMATION AT GLN-67. Tissue: Venom. |
| [5] | "Amino acid sequence of bradykinin-potentiating peptide isolated from the venom of Agkistrodon halys blomhoffii." Kato H., Suzuki T. Proc. Jpn. Acad., B, Phys. Biol. Sci. 46:176-181(1970) Cited for: PROTEIN SEQUENCE OF 85-95 AND 103-113, PYROGLUTAMATE FORMATION AT GLN-85 AND GLN-103. Tissue: Venom. |
| [6] | "cDNA cloning of bradykinin-potentiating peptides-C-type natriuretic peptide precursor, and characterization of the novel peptide Leu3-blomhotin from the venom of Agkistrodon blomhoffi." Murayama N., Michel G.H., Yanoshita R., Samejima Y., Saguchi K., Ohi H., Fujita Y., Higuchi S. Eur. J. Biochem. 267:4075-4080(2000) [PubMed] [Europe PMC] [Abstract] Cited for: SYNTHESIS OF 31-40 AND 49-59 (BPP-A AND LEU3-BLOMHOTIN), FUNCTION, PYROGLUTAMATE FORMATION AT GLN-49, MASS SPECTROMETRY. Tissue: Venom. |
| [7] | "Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides." Cotton J., Hayashi M.A., Cuniasse P., Vazeux G., Ianzer D., De Camargo A.C., Dive V. Biochemistry 41:6065-6071(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SYNTHESIS OF 67-77; 85-95 AND 103-113 (BPP-B AND BPP-C). |
| [8] | "Identification of novel bradykinin-potentiating peptides (BPPs) in the venom gland of a rattlesnake allowed the evaluation of the structure-function relationship of BPPs." Gomes C.L., Konno K., Conceicao I.M., Ianzer D., Yamanouye N., Prezoto B.C., Assakura M.T., Radis-Baptista G., Yamane T., Santos R.A., de Camargo A.C.M., Hayashi M.A.F. Biochem. Pharmacol. 74:1350-1360(2007) [PubMed] [Europe PMC] [Abstract] Cited for: SYNTHESIS OF 117-121 AND 131-136 (BPP-AHB1 AND BPP-AHB2), FUNCTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AB020810 mRNA. Translation: BAA36953.1. | ||||||||||||||||||
| PIR | XASNBA. A01254. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| HOVERGEN | HBG073115. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR000663. Natr_peptide. [Graphical view] | ||||||||||||||||||
| Pfam | PF00212. ANP. 1 hit. [Graphical view] | ||||||||||||||||||
| PRINTS | PR00710. NATPEPTIDES. | ||||||||||||||||||
| SMART | SM00183. NAT_PEP. 1 hit. [Graphical view] | ||||||||||||||||||
| PROSITE | PS00263. NATRIURETIC_PEPTIDE. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Entry information
| Entry name | BNP_GLOBL | ||||||||
| Accession | Primary (citable) accession number: P01021 Secondary accession number(s): Q9PT52 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Animal Toxin Annotation Program | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
